Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
The investigators compare the overall survival between combination chemotherapy and
monochemotherapy as a first-line chemotherapy in elderly patients with metastatic or
recurrent gastric cancer. The investigators also compare the progression free survival,
response rate, safety, and, quality of life between two groups, and evaluate that the
comprehensive geriatric assessment tested at baseline can predict the toxicity and compliance
of treatment, survival of the patients.
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Korean Cancer Study Group Ministry of Health & Welfare, Korea